Frontiers in Immunology, 2022
Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical Studies

Suhre K., Sarwath H., Engelke R. et al.

Aging, 2022
A catalogue of omics biological ageing clocks reveals substantial commonality and associations with disease risk

Macdonald-Dunlop E., Taba N., Klarić L. et al.

Environmental Research, 2022
Serum levels of perfluoroalkyl substances (PFAS) and body composition – A cross-sectional study in a middle-aged population

Lind P., Lind L., Salihovic S. et al.

European Journal of Heart Failure, 2022
Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction

Chandramouli C., Ting T., Tromp J. et al.

Atherosclerosis, 2022
Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk

Leonetti S., Tricò D., Nesti L. et al.

Frontiers in Immunology, 2022
Short Chain Fatty Acids Taken at Time of Thrombectomy in Acute Ischemic Stroke Patients Are Independent of Stroke Severity But Associated With Inflammatory Markers and Worse Symptoms at Discharge

Henry N., Frank J., McLouth C. et al.

The Lancet Respiratory Medicine, 2022
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis

Bowman W., Newton C., Linderholm A. et al.

Rheumatology, 2022
Clinical features and immune-related protein patterns of anti-MDA5 positive clinically amyopathic dermatomyositis Dutch patients

Hensgens M., Delemarre E., Drylewicz J. et al.

British Journal of Cancer, 2022
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer

Mukama T., Fortner R., Katzke V. et al.

eLife, 2022
Epigenetic scores for the circulating proteome as tools for disease prediction

Gadd D., Hillary R., McCartney D. et al.

Biomedicines, 2022
Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research

Palstrøm N., Matthiesen R., Rasmussen L. et al.

Annals of Allergy, Asthma & Immunology, 2022
Lower viral loads in subjects with rhinovirus-challenged allergy despite reduced innate immunity

Feng X., Lawrence M., Payne S. et al.

Clinical Cardiology, 2022
Proteomic differences among patients with heart failure taking furosemide or torsemide

Cooper L., Bruce S., Psotka M. et al.

Journal of Allergy and Clinical Immunology, 2022
Altered leukocyte subsets and immune proteome indicate proinflammatory mechanisms in mastocytosis

Hermans M., Heeringa J., Swagemakers S. et al.

Frontiers in Oncology, 2022
A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients

Xu F., Xu H., Wan Z. et al.

International Journal of Molecular Sciences, 2022
IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis

Wang X., Kaiser H., Kvist-Hansen A. et al.

European Journal of Heart Failure, 2022
Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure

Ceelen D., Voors A., Tromp J. et al.

Cell Reports Medicine, 2022
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study

Wesolowska-Andersen A., Brorsson C., Bizzotto R. et al.

British Journal of Dermatology, 2022
Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies*

Alavi A., Hamzavi I., Brown K. et al.

International Journal of Epidemiology, 2021
Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults

Kartsonaki C., Pang Y., Millwood I. et al.